Pierrel S.p.A.
Active in EUDAMEDItalyfrom SRN EUDAMED FDA SRN IT-MF-000029983 FEI 3006999064
- Devices
- 4
- Registrations
- EUDAMEDFDA
- FDA recalls
- 0
At a glance
Market reach
- European Union
- EUDAMED actor
- United States
- FDA FEI
What Pierrel S.p.A. makes
Pierrel S.p.A. makes GOCCLES, PLURAJECT 2 SYRINGE INCHTHREAD, PLURAJECT2 SYRINGE METRIC THREAD, and ORABLOC devices.
These devices are classified as Class I and are listed in the EUDAMED registry. The company is based in Italy.
Catalogue
Goccles Ref 531000601
Regimes: CE MDR Registry: EUDAMEDGUDIDPluraject 2 Syringe Inchthread Ref 2202006
Regimes: CE MDR Registry: EUDAMEDPLURAJECT2 Syringe Metric Thread Ref 2202005
Regimes: CE MDR Registry: EUDAMEDOrabloc Ref 20201212
Regimes: CE MDR Registry: EUDAMEDGUDID
Company details
- EUDAMED SRN
- IT-MF-000029983
- FDA FEI number
- 3006999064
- EU VAT number
- 04920860964
- EUDAMED status
- Active
- EUDAMED registered name
- Pierrel S.p.A.
- Registered address
- 46/48, Strada Statale Appia 7bis, 81043, Capua (CE), Italy
- Website
- www.pierrelgroup.com/
- [email protected]
- Phone
- +39 0823 626111
- PRRC contact
- Fabio Velotti
Frequently asked questions
How many devices does Pierrel S.p.A. have in the registry?
The registry currently lists 4 devices for Pierrel S.p.A.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Pierrel S.p.A.'s devices?
Among its 4 most recently registered devices, Pierrel S.p.A. has devices listed in EUDAMED (4 devices) and FDA GUDID (2 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Pierrel S.p.A.'s devices fall under?
Among its 4 most recently registered devices, the classes recorded for Pierrel S.p.A.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Pierrel S.p.A. in the registry?
The most recently registered devices listed for Pierrel S.p.A. include GOCCLES, PLURAJECT 2 SYRINGE INCHTHREAD, PLURAJECT2 SYRINGE METRIC THREAD and ORABLOC.